1-3 of 3
Jennifer Proctor
Close
Sort by
Journal Articles

A CD45-targeted antibody-drug conjugate successfully conditions for allogeneic hematopoietic stem cell transplantation in mice

Asim Saha, Sharon Hyzy, Tahirih Lamothe, Katelyn Hammond, Nicholas Clark, Leanne Lanieri, Prashant Bhattarai, Rahul Palchaudhuri, Geoffrey O. Gillard, Jennifer Proctor, Megan J. Riddle, Angela Panoskaltsis-Mortari, Margaret L. MacMillan, John E. Wagner, Hans-Peter Kiem, Lisa M. Olson, Bruce R. Blazar
Journal: Blood
Blood (2022) 139 (11): 1743–1759.
https://doi.org/10.1182/blood.2021012366
Published: 2022
Includes: Supplemental data
Journal Articles

The Potent PI3K-δ,γ Inhibitor, IPI-145, Exhibits Preclinical Activity In Murine and Human T-Cell Acute Lymphoblastic Leukemia

Xiaoyan Huang, MD., MSc, Jennifer Proctor, B.S., Yaling Yang, PhD, Xiuhua Gao, MD, PhD, Weihong Zhang, M.D., Shenjiao Huang, MD, PhD, Paul Changelian, PhD, Jeffery L. Kutok, MD, PhD, Karen McGovern, PhD, M. James You, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1438.
https://doi.org/10.1182/blood.V122.21.1438.1438
Published: 2013
Journal Articles

The Potent PI3K-δ,γ Inhibitor IPI-145 Exhibits Differential Activity In Diffuse Large B-Cell Lymphoma (DLBCL) Cell Lines

Veronica Campbell, BS, Ryan Thompson, PhD, Vivian Villegas, MS, Jennifer Proctor, B.S., Karen McGovern, PhD, Jeffery L. Kutok, MD, PhD, Howard M. Stern, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1832.
https://doi.org/10.1182/blood.V122.21.1832.1832
Published: 2013